Skip to main content
Fig. 5 | BMC Immunology

Fig. 5

From: Vaccinomic approach for novel multi epitopes vaccine against severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2)

Fig. 5

a The 3D model of the vaccine construct obtained after homology modelling on I-TASSER. b The 3D model was refined in modrefiner and galaxyrefiner and c the validated refined model was assessed by Ramachandran plot analysis that demonstrated 91.2%, 5.3% and 3.4% of protein residues in favoured, allowed, and disallowed (outlier) regions respectively. d ProSA-server, giving a Z-score of − 3.6

Back to article page